Holen Sie sich die Stockscreener-App
69.94
0.27%
-0.19
Handel nachbörslich:
70.00
0.06
+0.09%
Schlusskurs vom Vortag:
$70.13
Offen:
$70
24-Stunden-Volumen:
1.77M
Relative Volume:
0.50
Marktkapitalisierung:
$33.57B
Einnahmen:
$27.83B
Nettoeinkommen (Verlust:
$2.42B
KGV:
14.24
EPS:
4.9113
Netto-Cashflow:
$2.21B
1W Leistung:
-2.30%
1M Leistung:
-2.28%
6M Leistung:
+21.85%
1J Leistung:
+17.21%
1-Tages-Spanne:
$69.82
$70.51
1-Wochen-Bereich:
$69.45
$71.44
52-Wochen-Spanne:
$53.03
$85.36
Nutrien Ltd Stock (NTR) Company Profile
Firmenname
Nutrien Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare NTR vs CTVA, CF, ICL, MOS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTR
Nutrien Ltd
|
69.94 | 33.66B | 27.83B | 2.42B | 2.21B | 4.9113 |
CTVA
Corteva Inc
|
79.09 | 53.21B | 17.89B | 1.26B | 2.05B | 1.7029 |
CF
Cf Industries Holdings Inc
|
119.16 | 18.70B | 7.41B | 2.12B | 1.62B | 11.13 |
ICL
Icl Group Ltd
|
6.57 | 8.34B | 7.15B | 280.00M | 137.88M | 0.1749 |
MOS
Mosaic Company
|
22.62 | 7.15B | 12.05B | 575.40M | -534.60M | 1.6871 |
Nutrien Ltd Stock (NTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-03-26 | Herabstufung | UBS | Neutral → Sell |
| 2026-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-03-12 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-23 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2026-01-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-05 | Eingeleitet | National Bank Financial | Sector Perform |
| 2025-07-11 | Herabstufung | Jefferies | Buy → Hold |
| 2025-06-17 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-14 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-13 | Eingeleitet | Goldman | Sell |
| 2025-01-21 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-01-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2025-01-13 | Hochstufung | Piper Sandler | Underweight → Overweight |
| 2024-12-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-10-10 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-10 | Herabstufung | Goldman | Buy → Neutral |
| 2024-08-02 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2024-04-29 | Hochstufung | Berenberg | Hold → Buy |
| 2024-03-26 | Eingeleitet | Jefferies | Buy |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-29 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-02-23 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-01-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-30 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2023-11-14 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-08-14 | Herabstufung | Barclays | Overweight → Underweight |
| 2023-07-31 | Hochstufung | TD Securities | Hold → Buy |
| 2023-07-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-17 | Herabstufung | Berenberg | Buy → Hold |
| 2023-05-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-04-10 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-02-08 | Herabstufung | TD Securities | Buy → Hold |
| 2023-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-01-09 | Fortgesetzt | Credit Suisse | Underperform |
| 2022-11-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-03 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2022-10-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2022-08-09 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2022-07-14 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-03-28 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2022-03-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-02-18 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2021-12-17 | Eingeleitet | Piper Sandler | Neutral |
| 2021-10-13 | Eingeleitet | Mizuho | Neutral |
| 2021-09-14 | Bestätigt | BofA Securities | Buy |
| 2021-06-29 | Hochstufung | Susquehanna | Neutral → Positive |
| 2021-06-15 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-05-24 | Hochstufung | HSBC Securities | Hold → Buy |
| 2021-02-23 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-01-12 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2020-12-03 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-08-25 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-05-14 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-05-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-04-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-03-26 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-02 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-03-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-27 | Hochstufung | Berenberg | Hold → Buy |
| 2020-02-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-02-10 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-01-23 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-01-15 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2019-11-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-09-23 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-08-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-04-23 | Bestätigt | Cowen | Outperform |
| 2019-03-06 | Bestätigt | Cowen | Outperform |
| 2018-12-13 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Nutrien Ltd Aktie (NTR) Neueste Nachrichten
Nutrien Ltd. stock falls Monday, underperforms market - MarketWatch
Nutrien (NTR) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Nutrien Ltd at BMO Capital Markets Global Farm to Market Conference Transcript - GuruFocus
Nutrien Ltd. stock rises Friday, still underperforms market - MarketWatch
National Energy still demanding port fees from Nutrien months after closure - Trinidad Guardian
NTR Stock Chart | NUTRIEN LTD (NYSE:NTR) - ChartMill
Here's why Nutrien (NTR) is a strong momentum stock - MSN
Nutrien Ltd. stock rises Thursday, still underperforms market - MarketWatch
Nutrien Reviews Trinidad Nitrogen Fertilizer Assets Amid Global Portfolio Optimization - Global Agriculture
Is Nutrien Navigating a Shifting Fertilizer Landscape - Kavout
Nutrien Ltd. stock falls Wednesday, underperforms market - MarketWatch
Nutrien Ltd. stock remains steady Tuesday, still outperforms market - MarketWatch
Here's Why Nutrien (NTR) is a Strong Momentum Stock - Yahoo Finance
Raymond James reiterates Nutrien stock rating on potash price gains - Investing.com
Nutrien’s SWOT analysis: fertilizer stock navigates cost cuts - Investing.com
Nutrien’s SWOT analysis: fertilizer stock navigates cost cuts By Investing.com - Investing.com Canada
NTR.CA Stock Chart | NUTRIEN LTD (TSX:NTR) - ChartMill
Nutrien Plans to Sell Overseas Nitrogen Fertilizer Assets to Advance Global Business Strategy Optimization - ChemNet
Oppenheimer Maintains Nutrien(NTR.US) With Buy Rating, Raises Target Price to $82 - Moomoo
Oppenheimer reiterates Nutrien stock rating on portfolio strength - Investing.com UK
Oppenheimer reiterates Nutrien stock rating on portfolio strength By Investing.com - Investing.com Nigeria
Nutrien (NTR) Stock Price, News & Analysis $NTR - MarketBeat
Tranche Update on Nutrien Ltd.'s Equity Buyback Plan announced on February 18, 2026. - marketscreener.com
ETFs Investing in Nutrien Ltd. Stocks - TradingView
Nutrien Ltd stock (CA67077M1086): What investors are watching after the latest catalyst - AD HOC NEWS
Nutrien (TSX:NTR) Is Up 5.3% After Q1 Results And Trinidad Review News Is The Bull Case Changed? - Yahoo Finance
Nutrien Weighs Asset Sales To Refocus Earnings Quality And Cash Flow - Yahoo Finance
Assessing Nutrien (TSX:NTR) Valuation After Strong Q1 EBITDA And Record Potash Volumes - simplywall.st
Nutrien Ltd. stock rises Friday, outperforms market - MarketWatch
Why Canadian Potash Giant Nutrien Picked A US Port - thedeepdive.ca
Nutrien Ltd. stock falls Thursday, underperforms market - MarketWatch
Trading the Move, Not the Narrative: (NTR) Edition - Stock Traders Daily
Specialty Fertilizers Market is expected to Hit US$ 110.4 - openPR.com
Nutrien Ltd. 2026 Q1ResultsEarnings Call Presentation (TSX:NTR:CA) 2026-05-13 - Seeking Alpha
BASF and Nutrien Collaborate on Expanding Farmer Access to Biofuel Markets - renewableenergymagazine.com
Nutrien Q1 Earnings Call Highlights - MarketBeat
NTR Maintained by Oppenheimer -- Price Target Raised to $82.00 - GuruFocus
Nutrien Ltd (NTR) Shares Surge 5.3% -- What GF Score of 71 Tells Investors - GuruFocus
Sidebar: Nutrien moves ahead on new-technology fertilizer plant - Petroleum News
Nutrien’s Portfolio Shift Gains Attention On The TSX Composite Index - Kalkine Media
Nutrien Ltd. stock rises Tuesday, outperforms market - MarketWatch
Is Nutrien (TSX:NTR) Quietly Rebuilding Its Portfolio Around Higher‑Quality, Cash‑Generative Assets? - simplywall.st
Oppenheimer Adjusts Price Target on Nutrien to $82 From $80, Maintains Outperform Rating - marketscreener.com
First Eagle Investment Management LLC Buys 70,068 Shares of Nutrien Ltd. $NTR - MarketBeat
NTR.CA Stock Price, Quote & Chart | NUTRIEN LTD (TSX:NTR) - ChartMill
Is Nutrien Ltd (NTR) Overvalued After 4.3% Rally? GF Value Says - GuruFocus
NTR Maintained by UBS -- Price Target Lowered to $65.00 - GuruFocus
Nutrien Ltd. stock rises Monday, outperforms market - MarketWatch
NTR Maintained by JP Morgan -- Price Target Raised to $80 - GuruFocus
Nutrien Supported by Strong Execution, Fertilizer Fundamentals, RBC Says - marketscreener.com
NTR Maintained by Scotiabank -- Price Target Raised to $80 - GuruFocus
Finanzdaten der Nutrien Ltd-Aktie (NTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):